New genes regulating melanocyte biology and melanogenesis have been identif
ied. Furthermore, the dissection of the cell signalling pathways involved i
n the control of melanogenesis is on the way. These advances have provided
the bulk of new information that should lead to an improvement of our thera
peutic armamentarium to treat melanin pigmentary disorders. In recent years
, there have been few drugs for pigmentary disorders that have reached the
clinic, Recent progress in this held has provided an impressive list of pot
ential targets for pharmacological intervention on melanocytes and melanoge
nesis. Given the role of melanocytes and melanins in the natural photoprote
ction of the skin, a better understanding of the mechanisms controlling mel
anogenesis should lead to new and safe strategies to correct abnormal skin
colour and to improve the skin's defence against the deleterious effects of
chronic and excessive exposure to sunlight. This review describes the rece
nt developments in melanocyte biology and melanogenesis, as well as possibl
e implications for future therapeutic strategies.